本頁面由Tiger Trade Technology Pte. Ltd.提供服務

百濟神州

346.51
+4.711.38%
盤後345.56-0.9500-0.27%19:30 EDT
成交量:30.78萬
成交額:1.07億
市值:395.02億
市盈率:61.99
高:349.08
開:345.11
低:341.22
收:341.80
52周最高:385.22
52周最低:253.95
股本:1.14億
流通股本:8,095.27萬
量比:0.64
換手率:0.38%
股息:- -
股息率:- -
每股收益(TTM):5.59
每股收益(LYR):2.47
淨資產收益率:14.66%
總資產收益率:7.46%
市淨率:7.63
市盈率(LYR):140.29

資料載入中...

2026/05/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/06

重要事件披露

Form 8-K - Current report
2026/05/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/14

重要事件披露

Form 8-K - Current report
2026/02/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/19

重要事件披露

Form 8-K - Current report
2025/12/18

重要事件披露

Form 8-K - Current report
2025/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/19

重要事件披露

Form 8-K - Current report
2025/11/17

關聯方擬減持公告

Form 144 | BeOne Medicines Ltd. 高管 Xiaobin Wu 擬減持3991股,總價約151.83萬美元
2025/11/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities